ArticleOrganic & biomolecular chemistry2023

Synthesis of optically active SARS-CoV-2 Mpro inhibitor drug nirmatrelvir (Paxlovid): an approved treatment of COVID-19.

Arun K Ghosh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.